Axio BioPharma Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.4M
- Investors
-
4
Axio BioPharma General Information
Description
Developer of a biomanufacturing data coordination platform designed to connect pharmaceutical companies with their manufacturing partners and make data usable across different systems. The company offers data translation and coordination technology that keeps data in existing systems, along with non-GMP monoclonal antibody production services, enabling pharmaceutical companies and manufacturing partners to compare and use process data without transferring or centralizing it.
Contact Information
Website
www.axiobiopharma.comCorporate Office
- 504 South Rosa Road
- Suite 200
- Madison, WI 53719
- United States
Corporate Office
- 504 South Rosa Road
- Suite 200
- Madison, WI 53719
- United States
Axio BioPharma Timeline
Axio BioPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 21-Sep-2026 | $2.4M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 26-Aug-2026 | Completed | Generating Revenue | |||
| 2. Angel (individual) | $58.3K | $58.3K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Axio BioPharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Axio BioPharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Axio BioPharma Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chemical Angel Network | Angel Group | Minority | ||
| Elmstead Partners | Corporation | Minority | ||
| Plug and Play | Accelerator/Incubator | |||
| Silicon Valley Advantage | Accelerator/Incubator |
Axio BioPharma FAQs
-
When was Axio BioPharma founded?
Axio BioPharma was founded in 2024.
-
Where is Axio BioPharma headquartered?
Axio BioPharma is headquartered in Madison, WI.
-
What is the size of Axio BioPharma?
Axio BioPharma has 9 total employees.
-
What industry is Axio BioPharma in?
Axio BioPharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Axio BioPharma a private or public company?
Axio BioPharma is a Private company.
-
What is the current valuation of Axio BioPharma?
The current valuation of Axio BioPharma is .
-
What is Axio BioPharma’s current revenue?
The current revenue for Axio BioPharma is .
-
How much funding has Axio BioPharma raised over time?
Axio BioPharma has raised $2.46M.
-
Who are Axio BioPharma’s investors?
Chemical Angel Network, Elmstead Partners, Plug and Play, and Silicon Valley Advantage have invested in Axio BioPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
